{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T17:09:09Z","timestamp":1793639349293,"version":"4.5.1"},"reference-count":45,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:00:00Z","timestamp":1774569600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006093","name":"PCORI","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006093","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006458","name":"Children's Hospital of Philadelphia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006458","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jaci.2026.03.010","type":"journal-article","created":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T17:56:13Z","timestamp":1774461373000},"page":"533-541","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Incidence of autoimmune diseases in children with atopy treated with dupilumab"],"prefix":"10.1016","volume":"158","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0282-8533","authenticated-orcid":false,"given":"Stanislaw J.","family":"Gabryszewski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"Hirabayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgan","family":"Botdorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchell","family":"Maltenfort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher B.","family":"Forrest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa W.","family":"Guilbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeline","family":"Schutt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Morizono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerardo","family":"Vazquez Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Cristina","family":"Garza-Mayers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph Demetrius","family":"Hernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Anvari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suchitra","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan M.","family":"Spergel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2026.03.010_bib1","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1007\/s00403-023-02544-2","article-title":"Quality of life of pediatric patients with atopic dermatitis and their caregivers","volume":"315","author":"El Achkar Mello","year":"2023","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.jaci.2026.03.010_bib2","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.3889\/oamjms.2018.287","article-title":"Quality of life in children with asthma versus healthy children","volume":"6","author":"Kouzegaran","year":"2018","journal-title":"Open Access Maced J Med Sci"},{"key":"10.1016\/j.jaci.2026.03.010_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.xjidi.2022.100131","article-title":"Type 2 inflammation contributes to skin barrier dysfunction in atopic dermatitis","volume":"2","author":"Beck","year":"2022","journal-title":"JID Innov"},{"key":"10.1016\/j.jaci.2026.03.010_bib4","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1038\/ni.3829","article-title":"The immunology of the allergy epidemic and the hygiene hypothesis","volume":"18","author":"Lambrecht","year":"2017","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaci.2026.03.010_bib5","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3389\/fped.2017.00044","article-title":"The nose and the lung: united airway disease?","volume":"5","author":"Licari","year":"2017","journal-title":"Front Pediatr"},{"key":"10.1016\/j.jaci.2026.03.010_bib6","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1007\/s13555-022-00737-7","article-title":"Current and emerging strategies to inhibit type 2 inflammation in atopic dermatitis","volume":"12","author":"Haddad","year":"2022","journal-title":"Dermatol Ther (Heidelb)"},{"key":"10.1016\/j.jaci.2026.03.010_bib7","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/nrd4624","article-title":"Targeting key proximal drivers of type 2 inflammation in disease","volume":"15","author":"Gandhi","year":"2016","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.jaci.2026.03.010_bib8","doi-asserted-by":"crossref","first-page":"270","DOI":"10.3390\/ph16020270","article-title":"Biologic therapies for asthma and allergic disease: past, present, and future","volume":"16","author":"Ram\u00edrez-Jim\u00e9nez","year":"2023","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.jaci.2026.03.010_bib9","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/imr.13230","article-title":"Engineering the IL-4\/IL-13 axis for targeted immune modulation","volume":"320","author":"Bernstein","year":"2023","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jaci.2026.03.010_bib10","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/S0140-6736(22)01539-2","article-title":"Dupilumab in children aged 6 months to younger than 6 years with uncontrolled atopic dermatitis: a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"400","author":"Paller","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2026.03.010_bib11","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1056\/NEJMoa1804093","article-title":"Efficacy and safety of dupilumab in glucocorticoid-dependent severe asthma","volume":"378","author":"Rabe","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2026.03.010_bib12","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1146\/annurev.immunol.21.120601.140942","article-title":"Molecular mechanisms regulating Th1 immune responses","volume":"21","author":"Szabo","year":"2003","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.jaci.2026.03.010_bib13","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1016\/j.jid.2024.05.015","article-title":"Paradoxical psoriasis: an updated review of clinical features, pathogenesis, and treatment options","volume":"144","author":"Maronese","year":"2024","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2026.03.010_bib14","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/ced\/llad390","article-title":"Dupilumab-associated inflammatory arthritis: a literature review","volume":"49","author":"Napolitano","year":"2024","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaci.2026.03.010_bib15","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1056\/NEJMms2029562","article-title":"Race and genetic ancestry in medicine\u2014a time for reckoning with racism","volume":"384","author":"Borrell","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2026.03.010_bib16","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.acap.2018.02.010","article-title":"Development and validation of the pediatric medical complexity algorithm (PMCA) version 3.0","volume":"18","author":"Simon","year":"2018","journal-title":"Acad Pediatr"},{"key":"10.1016\/j.jaci.2026.03.010_bib17","author":"Greifer"},{"key":"10.1016\/j.jaci.2026.03.010_bib18","author":"Greifer"},{"key":"10.1016\/j.jaci.2026.03.010_bib19","author":"Lenth"},{"key":"10.1016\/j.jaci.2026.03.010_bib20","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1056\/NEJMoa1804092","article-title":"Dupilumab efficacy and safety in moderate-to-severe uncontrolled asthma","volume":"378","author":"Castro","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2026.03.010_bib21","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1001\/jamadermatol.2019.3336","article-title":"Efficacy and safety of dupilumab in adolescents with uncontrolled moderate to severe atopic dermatitis: a phase 3 randomized clinical trial","volume":"156","author":"Simpson","year":"2020","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaci.2026.03.010_bib22","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.jaad.2020.06.054","article-title":"Efficacy and safety of dupilumab with concomitant topical corticosteroids in children 6 to 11 years old with severe atopic dermatitis: a randomized, double-blinded, placebo-controlled phase 3 trial","volume":"83","author":"Paller","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaci.2026.03.010_bib23","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1056\/NEJMoa2106567","article-title":"Dupilumab in children with uncontrolled moderate-to-severe asthma","volume":"385","author":"Bacharier","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2026.03.010_bib24","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s12016-022-08934-0","article-title":"Dupilumab-associated adverse events during treatment of allergic diseases","volume":"62","author":"Kychygina","year":"2022","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.jaci.2026.03.010_bib25","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1159\/000530608","article-title":"Dupilumab-associated psoriasis and psoriasiform manifestations: a scoping review","volume":"239","author":"Su","year":"2023","journal-title":"Dermatology"},{"key":"10.1016\/j.jaci.2026.03.010_bib26","doi-asserted-by":"crossref","DOI":"10.1111\/dth.13142","article-title":"Occurrence of psoriasiform eruption during dupilumab therapy for adult atopic dermatitis: a case series","volume":"32","author":"Napolitano","year":"2019","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.jaci.2026.03.010_bib27","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/DER.0000000000000509","article-title":"Psoriasis-like dermatitis developing in a patient with atopic dermatitis treated with dupilumab","volume":"30","author":"Stout","year":"2019","journal-title":"Dermatitis"},{"key":"10.1016\/j.jaci.2026.03.010_bib28","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.alit.2020.02.004","article-title":"An asthmatic case of psoriasiform eruption caused by administration of dupilumab","volume":"69","author":"Matsuda","year":"2020","journal-title":"Allergol Int"},{"key":"10.1016\/j.jaci.2026.03.010_bib29","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/1346-8138.16595","article-title":"Dupilumab-induced skin-associated side effects in patients with chronic rhinosinusitis with nasal polyposis","volume":"50","author":"Chromy","year":"2023","journal-title":"J Dermatol"},{"key":"10.1016\/j.jaci.2026.03.010_bib30","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1111\/pde.14820","article-title":"Psoriasiform dermatitis during dupilumab treatment for moderate-to-severe atopic dermatitis in children","volume":"38","author":"Parker","year":"2021","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.jaci.2026.03.010_bib31","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1001\/jamadermatol.2025.1578","article-title":"Psoriasis risk in patients with atopic dermatitis treated with dupilumab","volume":"161","author":"Lin","year":"2025","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaci.2026.03.010_bib32","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1080\/1744666X.2017.1279054","article-title":"The role of IL-4 in psoriasis","volume":"13","author":"Hahn","year":"2017","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.jaci.2026.03.010_bib33","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.annder.2021.02.003","article-title":"Dupilumab-induced psoriasis and alopecia areata: case report and review of the literature","volume":"148","author":"Beaziz","year":"2021","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.jaci.2026.03.010_bib34","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.jaad.2019.06.010","article-title":"Cause or cure? Review of dupilumab and alopecia areata","volume":"88","author":"Marks","year":"2023","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaci.2026.03.010_bib35","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1002\/art.42558","article-title":"Characterization of a musculoskeletal syndrome of enthesitis and arthritis in patients with atopic dermatitis treated with dupilumab, an interleukin-4\/13 inhibitor","volume":"75","author":"Hughes","year":"2023","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jaci.2026.03.010_bib36","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1111\/bjd.18031","article-title":"Development of inflammatory arthritis and enthesitis in patients on dupilumab: a case series","volume":"181","author":"Willsmore","year":"2019","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2026.03.010_bib37","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.jaci.2022.03.030","article-title":"Atopic dermatitis and risk of autoimmune conditions: population-based cohort study","volume":"150","author":"de Lusignan","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.03.010_bib38","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/jid.2008.259","article-title":"Atopic dermatitis: a disease caused by innate immune defects?","volume":"129","author":"De Benedetto","year":"2009","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2026.03.010_bib39","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/MCP.0000000000000342","article-title":"T2-low asthma: current approach to diagnosis and therapy","volume":"23","author":"Samitas","year":"2017","journal-title":"Curr Opin Pulm Med"},{"key":"10.1016\/j.jaci.2026.03.010_bib40","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1016\/j.jaci.2016.04.007","article-title":"Role of IgE in autoimmunity","volume":"137","author":"Sanjuan","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.03.010_bib41","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jaci.2024.05.007","article-title":"Th2-driven manifestations of inborn errors of immunity","volume":"154","author":"James","year":"2024","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.03.010_bib42","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.4049\/jimmunol.2000973","article-title":"Conserved IFN signature between adult and pediatric eosinophilic esophagitis","volume":"206","author":"Ruffner","year":"2021","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2026.03.010_bib43","article-title":"Refractory dupilumab-induced inflammatory arthritis treated by upadacitinib: a \u201cJanus kinase (JAK)\u201d of all trades","volume":"16","author":"Cooper","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/j.jaci.2026.03.010_bib44","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1159\/000539124","article-title":"Janus kinase inhibitors as successful treatment alternative in dupilumab-induced psoriasis","volume":"16","author":"Weiss","year":"2024","journal-title":"Case Rep Dermatol"},{"key":"10.1016\/j.jaci.2026.03.010_bib45","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jaad.2024.03.007","article-title":"Use of dual biologic therapy targeting the Th2 and Th17 axes simultaneously to treat patients with atopic dermatitis and concomitant psoriasis, psoriatic arthritis, or inflammatory bowel disease","volume":"91","author":"Hren","year":"2024","journal-title":"J Am Acad Dermatol"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674926002149?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674926002149?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T05:37:34Z","timestamp":1793597854000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674926002149"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S0091674926002149"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2026.03.010","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incidence of autoimmune diseases in children with atopy treated with dupilumab","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2026.03.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.","name":"copyright","label":"Copyright"}]}}